RE:New 52 week lowFinancials...improving towards eventual profitability...this is all that matters...regular P/R's only benefit penny flipping day traders...triple digit revenue growth thanks to the Vivo aqusition, organic growth and pharmaceutical progress will lead to profitability IMO....despite the share price im very pleased with the direction...I'm here because I believe Labs is in position to become THE cannabinoid pharmaceutical partner for the emerging 128 Billion $ market. Things are clearly going very well except for the share price...this will change...IMO...